Dahl Chase Diagnostic Services

What Dahl Chase Diagnostic Services does

Dahl-Chase Diagnostic Services (DCDS) is the technical and operational laboratory arm of Dahl-Chase Pathology Associates, P.A. (DCPA), a pathology group practice founded in 1971 and headquartered in Bangor, Maine. The company provides clinical and anatomic pathology laboratory services to 18 hospitals across the full span of Maine (from Fort Kent to Kittery), regional physician practices, and a national client base that includes state fishery and wildlife agencies. Operating with 15 board-certified pathologists covering subspecialties including hematopathology, dermatopathology, and molecular pathology, supported by 51-100 technical and administrative staff, DCDS processes 80,000+ surgical specimens and produces 200,000+ H&E slides annually. The laboratory is CAP- and CLIA-certified.

The platform combines a PowerPath laboratory information system (LIS) with a Motic whole slide scanner for digital pathology, Roche Cobas 4800 instrumentation, and a menu that includes next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), multi-antigen flow cytometry, and a proprietary paroxysmal nocturnal hemoglobinuria (PNH) detection method reported as first-in-Maine. Specimen logistics are supported through partial ownership of UniShip Courier Services, giving DCDS vertical control over transport across its rural service region.

DCDS generates revenue primarily on a fee-for-service basis for anatomic and clinical pathology testing billed to hospital systems, physician offices, and specialty accounts. Strategic partnerships with Versant Northeast and Versant DermPath extend the firm's reach into molecular oncology and dermatopathology channels beyond direct Maine hospital relationships, and a national wildlife/fishery testing program provides non-healthcare revenue diversification. The 50+ year operating history, integrated logistics, and embedded LIS relationships across 18 hospitals form the operational backbone of the business.

Name

Dahl Chase Diagnostic Services

Legal name

Dahl-Chase Diagnostic Services

Website

https://dahlchase.net

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

51–100 employees

Short description

Dahl-Chase Diagnostic Services is the laboratory arm of a Bangor, Maine-based pathology group, providing clinical and anatomic pathology testing to 18 Maine hospitals, physician practices, and national specialty clients, supported by 15 board-certified pathologists and advanced molecular diagnostics.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology Laboratory Services

NAICS

Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Misc Health & Allied Services, Nec (8090), Services-Management Services (8741)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

akta.pro secondary industries

Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics) (HLAHAAAE), Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays (HLAAALAN), Home Healthcare & DME Delivery (Oxygen, Supplies) (TLAAAIAE)

Keywords

• Anatomic pathology services
• Clinical pathology laboratory
• Surgical pathology testing
• Molecular diagnostic services
• Histology laboratory services

Headquarters

HQ city

Bangor

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Pathology Professional Interpretation Fees: Pathologists (members of Dahl-Chase Pathology Associates, P.A.) charge a fee for diagnostic interpretation of surgical specimens and laboratory tests rendered to ordering clinicians, hospitals and patients. Billed through the patient's physician or directly via insurance/pay billing.
2. Technical Component Laboratory Testing Fees: Dahl-Chase Diagnostic Services (DCDS) acts as the technical backbone, processing tissues and specimens (surgical pathology, histology, immunohistochemistry, cytology, flow cytometry, molecular diagnostics) and billing the technical component to hospitals, physician offices, and patients.
3. Patient Self-Pay and Insurance Reimbursement: Patient billing via insurance (carrier billed when correct info provided) and self-pay with statement within 15 days; offers budget plans, financial assistance discounts for qualifying patients; delinquent accounts turned over to collection agency Marcam Associates.
4. Wildlife and Fishery Cementum Aging Analysis Services: Detailed cementum aging analysis slides for the State of Maine Wildlife and Fishery Services and other state wildlife/fishery departments nationwide; quote-based pricing with 6-week turnaround.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Core offering

Dahl-Chase Diagnostic Services (DCDS) is a CAP-accredited, CLIA-certified pathology laboratory serving as the technical backbone of Dahl-Chase Pathology Associates, P.A. — a 15-pathologist professional group. DCDS processes surgical, histologic, cytologic, hematopathologic, flow cytometry, and molecular specimens for hospitals, physician offices, clinics, and state wildlife/fishery departments, while also providing telepathology, EMR/HIS interfacing, and backup pathology coverage.

Product overview

Dahl-Chase Diagnostic Services (DCDS) operates as a state-of-the-art pathology laboratory that serves as the technical backbone for Dahl-Chase Pathology Associates, a separate but related 15-pathologist professional group founded in 1971. The offering is organized as a unified diagnostic laboratory platform composed of multiple subspecialty service modules — Surgical Pathology, Histology, Molecular Pathology, Hematopathology, Flow Cytometry, PNH Testing, Cytopathology, Dermatopathology, Gastrointestinal Pathology, Genitourinary Pathology, Clinical Pathology, and Wildlife Testing — supported by a Support Services module that delivers telepathology (via Motic whole slide scanner), EMR/HIS interfacing through PowerPath, Zoom-based interdisciplinary conferencing, and backup pathology coverage to 18 Maine hospitals and clients across the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Surgical Pathology Handles over 80,000 specimens annually; pathology technicians and certified Pathologists' Assistants provide gross descriptions, tissue handling, and histology submission, with each specimen bar-coded for tracking and patient identity verification. For hospitals, physician offices, and clinics.
• Histology Full-service histology laboratory processing approximately 60,000 surgical specimens per year and producing over 200,000 H&E slides, with 1-2 working day turnaround and an extensive menu of special stains and immunohistochemistry tests including kappa, lambda, and Epstein Barr Virus in-situ hybridization staining. For hospitals, physician offices, and clinics.
• Molecular Pathology Molecular analysis of solid tumors, hematopathology FISH testing, and infectious disease testing on cytology specimens, including FISH for HER2, KRAS/NRAS/BRAF mutation analysis, microsatellite instability, EGFR mutational analysis, ALK/ROS1/RET rearrangements, MET amplification, HPV, and GC/Chlamydia testing. For hospitals, oncologists, and reference labs.
• Hematopathology Full-service diagnostic evaluation of blood, bone marrow, lymph nodes, and other hematopoietic and lymphoid tissues, integrating light microscopy, immunohistochemistry, flow cytometry, and molecular diagnostics into comprehensive reports. For hospitals and hematology/oncology practices.
• Flow Cytometry Client-oriented, full-service flow cytometry laboratory offering immunodeficiency evaluation, leukemia/lymphoma evaluation, PNH high-sensitivity screening, DNA ploidy and cell cycle analysis, and fetal hemoglobin evaluation on instruments capable of simultaneously examining up to 10 different antigens. For hospitals, hematology/oncology practices, and reference labs.
• PNH Testing High-sensitivity paroxysmal nocturnal hemoglobinuria screening for hematology/oncology practices, leveraging a method Dahl-Chase helped develop that became the national standard for detecting minor PNH clones.
• Cytopathology Liquid-based Pap testing using the SurePath methodology with HPV testing via the Roche Cobas 4800 assay, as well as non-gynecologic cytology and fine needle aspiration interpretation from multiple body sites, with 7-10 working day Pap turnaround. For hospitals, physician offices, and gynecologists.
• Dermatopathology Skin specimen review and interpretation by two board-certified dermatopathologists, with monthly dermatopathology conferences for clinicians and support for immunofluorescence cases submitted in Zeus medium. For dermatology practices, hospitals, and clinics.
• Gastrointestinal Pathology Subspecialty gastrointestinal pathology team providing diagnoses for diseases of the GI tract and liver, with in-house NGS-based testing for KRAS, BRAF, NRAS mutations and microsatellite instability in colorectal adenocarcinomas. For gastroenterologists, hospitals, and oncology practices.
• Genitourinary Pathology Urological tissue evaluation with second-pathologist review of prostate needle biopsies and IHC stains to confirm small carcinomas, supported by regular GU pathology conferences with referring urologists and oncologists. For urology practices, hospitals, and oncologists.
• Clinical Pathology Expert consultation across Clinical Chemistry, Coagulation, Hematology, Immunology, Microbiology, Toxicology, Transfusion Medicine, and Urinalysis, with board-certified pathologists and three full-time Medical Technologists supporting a Clinical Laboratory Advisory Committee. For hospitals, clinics, and reference labs.

Quantifiable outcome

• Processes over 80,000 surgical specimens annually
• +6 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature7 records

Partnerships

Five partnerships are on record, tiered flagship, core and minor.

• Versant (Versant Northeast + Versant DermPath)flagshipStrategic or Co-development PartnerDahl-Chase is now partnered with Versant Northeast and Versant DermPath, as displayed prominently on the homepage with linked logo to versantdx.com. Represents a flagship dermatopathology/regional strategic partnership.
• UniShip Courier Services, LLCcoreChannel Partner/ Reseller/ DistributorDahl-Chase Pathology Associates has partial ownership in UniShip Courier Services, LLC; used to guarantee very prompt turnaround times for specimen pickup and delivery across the region. UniShip is referenced throughout the website (clients, contact, and support services pages) and serves as the integrated logistics backbone.
• Marcam AssociatesminorImplementation/ SI/ Consulting PartnerDahl-Chase uses Marcam Associates as its collection agency for patient accounts turned over for non-payment. Patients are directed to contact Marcam (1-800-638-1005) to make a payment or set up a payment plan once the account has been transferred.
• PHD ConsultingminorImplementation/ SI/ Consulting PartnerPHD Consulting (phdcon.com) is credited as the website designer in the footer of the dahlchase.net site.
• Roche (Cobas 4800)coreTechnology or IntegrationHPV testing performed utilizing the Roche Cobas 4800 assay as part of Dahl-Chase's combined gynecologic cytopathology report (Pap + HPV genotyping). Represents a core instrument/vendor relationship for HPV molecular testing.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• PathGroup: Pathologist-owned anatomic and clinical pathology platform serving hospitals and physicians across the Southeast U.S. Closest comparable to Dahl-Chase in ownership model (pathologist-led), subspecialty depth, and hospital-channel distribution.
• ProPath Services: Specialty pathology practice offering surgical pathology, molecular diagnostics, and dermatopathology with subspecialty-trained pathologists. Comparable to Dahl-Chase in service mix and subspecialty-driven positioning.
• Aurora Diagnostics: Multi-site anatomic pathology platform operating regional pathology practices with hospital and physician-office channels. Directly comparable to Dahl-Chase in pathologist-led rollup model serving community hospitals.
• Inform Diagnostics: Specialty anatomic pathology provider (formerly Miraca Life Sciences) focused on GI, dermatopathology, urology, and breast pathology with subspecialty interpretation. Highly comparable subspecialty mix to Dahl-Chase.
• CellNetix Pathology & Laboratories: Pathologist-owned regional pathology group serving hospitals and clinics in the Pacific Northwest with surgical pathology, molecular, and subspecialty services. Comparable independent, pathologist-owned regional lab model.

Broad incumbents

• Quest Diagnostics: National clinical reference laboratory offering routine and esoteric testing, anatomic pathology, and hospital outreach services. Competes for technical component and send-out work from hospital customers.
• Laboratory Corporation of America (Labcorp): Largest U.S. clinical laboratory network with full-service anatomic and clinical pathology, hospital outreach, and esoteric testing. Overlaps with Dahl-Chase on technical component and reference work.
• ARUP Laboratories: Academic medical center-affiliated national reference laboratory offering esoteric and subspecialty testing including molecular pathology and flow cytometry. Competes for send-out and specialized reference work.
• Sonic Healthcare USA: International diagnostics group with U.S. anatomic and clinical pathology operations acquired via American Pathology Partners and other regional labs. Competes in hospital-channel pathology services.

Emerging players

• NeoGenomics: Specialty oncology-focused molecular and anatomic pathology laboratory with growing flow cytometry and NGS offerings. Partial overlap with Dahl-Chase's molecular pathology and hematopathology services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/dahl-chase-diagnostic-services

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dahl Chase Diagnostic Services